×

Cramer Remix: Pay & play in the week ahead

Thursday night the world learned that a doctor in New York City has been diagnosed with Ebola after spending time in West Africa. The news immediately caused the index futures to take a nose dive.

However, it seems as though the public is beginning to recognize that this horrible disease might be harder to contract than initially thought 10 days ago when the market was in sheer terror over the case in Texas.

Despite Ebola fears, the Dow Jones industrial average (.DJI) ended the day up 127 points, and the S&P 500 (.SPX) closed up 13 points.

The "Mad Money" host thinks that next week will be stellar as well, barring more bad Ebola news, and shared his game plan with investors on the stocks that will be most influential next week:

Twitter (TWTR): It's one of the most controversial stocks around. The near-term is out of focus, but long-term, Cramer loves the business model and wants to own it not trade it.

Facebook (FB): "The expectations have gotten so high that we're advising people to do a little trimming before the quarter." The report won't be another doozy like Amazon, but Cramer has trepidation.

Starbucks (SBUX): The giant chain has hedged about 60 percent of its coffee costs, which means it's no longer a prisoner to the cost of coffee. Cramer thinks it's a buy into the quarter.

Chevron (CVX) and Exxon (XOM): Given how important oil is to the market, Cramer says we need to hear what these oil giants say about oil weakness due to glut of supply or lack of demand, or both.

Read MoreCramer: Ebola and earnings, oh my

Police officers stand guard as the members of the press work in front of Bellevue Hospital where the doctor who was diagnosed with the Ebola disease and has been kept in quarantine, Oct. 24, 2014, in New York.
Cem Ozdel | Anadolu Agency | Getty Images
Police officers stand guard as the members of the press work in front of Bellevue Hospital where the doctor who was diagnosed with the Ebola disease and has been kept in quarantine, Oct. 24, 2014, in New York.

Cramer has always said that bulls make money, bears make money, but greedy little hogs get slaughtered. With this information in mind, he has now circled back to one of his long-time favorites, Palo Alto Networks (PANW).

Though the "Mad Money" host still likes the company, he doesn't like the stock.

"I still think that Palo Alto is best of breed in the cybersecurity space. But I also think it's time for you to start selling Palo Alto Networks, because there's a limit to how much we'll pay even for the best of breed companies," said Cramer.

Now that there is cash in hand from Palo Alto, Cramer is looking at stocks to buy instead. With the launch of Apple Pay on Monday, we may be witnessing the end of the modern day wallet.

One stock in particular that Jim Cramer thinks will benefit from the move is VeriFone (PAY). It makes point-of-sale terminals compatible with the touchless technology behind Apple Pay and is right in the epicenter of this retail transition.

Though VeriFone is up more than 28 percent year to date, it could have a lot more upside. In fact, in the long term, if Cramer is right about the point of sale upgrade cycle, then he expects this stock to have a 40 percent increase over its current price.

There's even more in the pipeline, as it's not just Apple Pay that will boost VeriFone. From a security perspective, in 2015 credit cards will be coming out with new regulations that puts the responsibility for security breaches onto retailers. Credit cards will require the use of EMV chips to be installed into the cards, so that they cannot be duplicated.

Guess who has the EMV compatible terminals? VeriFone.

Read MoreThanks to Apple, this wins: Cramer

Apple Pay
Justin Solomon | CNBC
Apple Pay

The maker of Ugg boots and Teva sandals might have a rocky road ahead. Cramer spoke with Angel Martinez, the CEO of Deckers Outdoor (DECK), on Friday to find out what the heck is going on.

This company has made a notable comeback in the past 18 months and beat Wall Street's estimates on Thursday with higher than expected sales, up 24 percent year-over-year. However the stock was pummeled on Friday, as Deckers' forecast for the holidays was viewed as disappointing.

Was the stock unjustly punished, creating a unique buying opportunity?

"I must say Jim, I'm three things: I'm perplexed, I'm befuddled, and I'm stymied. Here we have a quarter in which we beat last year's results … in my mind these are good things, so I'm a little perplexed as to why that's a negative," said Martinez.

Ultimately Cramer thinks the selloff is a mistake and agrees with Martinez that this is a buying opportunity for Deckers.

Jim Cramer on set of Mad Money
CNBC

The great Albert Einstein defined insanity as "doing the same thing over and over again and expecting different results." Cramer thinks investors might have a case of market insanity on their hands.

With each new case of Ebola, the market balks. However, though index futures started out in the red on Friday, the market had a great rebound. Investors who did sell into the panic of Ebola ended up feeling like chumps at the end of the day.

"You might not want to jump the gun and sell aggressively the next time we find out that some doctor is suffering from a disease that's so far killed one person in this entire country," added Cramer.

Until this disease is under control, Cramer thinks investors need to accept that there is a contagious, often fatal disease, that could cause disruptions in the U.S. Life will go on, and Ebola will be contained if not eventually cured.

Read MoreCramer & Ebola: Market insanity?

As for the Lightning Round, Cramer shared his view on preparing for next week with a few caller favorite stocks:

The Southern Company (SO): "I like Southern, why? Because I like a good solid yield and grows the dividend over time."

Newlink Genetics (NLNK): "Do not hold this long-term. Sell half on Monday, it's way too speculative."